Sfoglia per Autore
Genetic variation in the interleukin-28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection
2011 F. Marabita, A.M. Aghemo, S. De Nicola, M. Rumi, C. Cheroni, R. Scavelli, M. Crimi, R.M. Soffredini, S. Abrignani, R. De Francesco, M. Colombo
Metabolism of phosphatidylinositol 4-kinase IIIα-dependent PI4P is subverted by HCV and is targeted by a 4-anilino quinazoline with antiviral activity
2012 A. Bianco, V. Reghellin, L. Donnici, S. Fenu, R. Alvarez, C. Baruffa, F. Peri, M. Pagani, S. Abrignani, P. Neddermann, R. de Francesco
Identification of new hematopoietic cell subsets with a polyclonal antibody library specific for neglected proteins
2012 M. Moro, M. Crosti, P. Creo, P. Gallina, S. Curti, E. Sugliano, R. Scavelli, D. Cattaneo, E. Canidio, M. Marconi, P. Rebulla, P. Sarmientos, G. Viale, M. Pagani, S. Abrignani
Circulating hepatitis B surface antigen particles carry hepatocellular microRNAs
2012 L. Novellino, R.L. Rossi, F. Bonino, D. Cavallone, S. Abrignani, M. Pagani, M.R. Brunetto
Follicular helper NKT cells induce limited B cell responses and germinal center formation in the absence of CD4 + T cell help
2012 E. Tonti, M. Fedeli, A. Napolitano, M. Iannacone, U.H. Von Andrian, L.G. Guidotti, S. Abrignani, G. Casorati, P. Dellabona
Identification of new autoantigens by protein array indicates a role for IL4 neutralization in autoimmune hepatitis
2012 C. Zingaretti, M. Arigò, A. Cardaci, M. Moro, M. Crosti, A. Sinisi, E. Sugliano, C. Cheroni, F. Marabita, R. Nogarotto, R.J.P. Bonnal, P. Marcatili, M. Marconi, A. Zignego, P. Muratori, P. Invernizzi, P. Colombatto, M. Brunetto, F. Bonino, R. De Francesco, J. Geginat, M. Pagani, L. Muratori, S. Abrignani, M. Bombaci
Third trimester amniotic fluid cells with the capacity to develop neural phenotypes and with heterogeneity among sub-populations
2012 D. Bottai, D. Cigognini, E. Nicora, M. Moro, M.G. Grimoldi, R. Adami, S. Abrignani, A.M. Marconi, A.M. Di Giulio, A. Gorio
Hepatitis C virus-specific directly acting antiviral drugs
2013 L. Delang, J. Neyts, I. Vliegen, S. Abrignani, P. Neddermann, R. De Francesco
Reduction of CD68(+) macrophages and decreased IL-17 expression in intestinal mucosa of patients with inflammatory bowel disease strongly correlate with endoscopic response and mucosal healing following infliximab therapy
2013 F. Caprioli, F. Bose, R. L. Rossi, L. Petti, C. Vigano, C. Ciafardini, L. Raeli, G. Basilisco, S. Ferrero, M. Pagani, D. Conte, G. Altomare, G. Monteleone, S. Abrignani, E. Reali
IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen-negative patients with chronic hepatitis B
2013 P. Lampertico, M. Viganò, C. Cheroni, F. Facchetti, F. Invernizzi, V. Valveri, R.M. Soffredini, S. Abrignani, R. De Francesco, M.G. Colombo
A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humans
2013 J.L.M. Law, C. Chen, J. Wong, D. Hockman, D.M. Santer, S.E. Frey, R.B. Belshe, T. Wakita, J. Bukh, C.T. Jones, C.M. Rice, S. Abrignani, D..L. Tyrrell, M. Houghton
Role of microRNAs and long-non-coding RNAs in CD4+ T-cell differentiation
2013 M. Pagani, G. Rossetti, I. Panzeri, P. de Candia, R.J. Bonnal, R.L. Rossi, J. Geginat, S. Abrignani
Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses
2013 G. Nizzoli, J. Krietsch, A. Weick, S. Steinfelder, F. Facciotti, P. Gruarin, A. Bianco, B. Steckel, M. Moro, M. Crosti, C. Romagnani, K. Stölzel, S. Torretta, L. Pignataro, C. Scheibenbogen, P. Neddermann, R. De Francesco, S. Abrignani, J. Geginat
Intracellular modulation, extracellular disposal and serum increase of MiR-150 mark lymphocyte activation
2013 P. De Candia, A. Torri, T. Gorletta, M. Fedeli, E. Bulgheroni, C. Cheroni, F. Marabita, M. Crosti, M. Moro, E. Pariani, L. Romanò, S. Esposito, F. Mosca, G. Rossetti, R.L. Rossi, J. Geginat, G. Casorati, P. Dellabona, M. Pagani, S. Abrignani
The CD4-centered universe of human T cell subsets
2013 J. Geginat, M. Paroni, F. Facciotti, P. Gruarin, I. Kastirr, F. Caprioli, M. Pagani, S. Abrignani
Plasticity of human CD4 T cell subsets
2014 J. Geginat, M. Paroni, S. Maglie, J.S. Alfen, I. Kastirr, P. Gruarin, M. de Simone, M. Pagani, S. Abrignani
IL-21 is a central memory T cell-associated cytokine that inhibits the generation of pathogenic Th1/17 effector cells
2014 I. Kastirr, S. Maglie, M. Paroni, J.S. Alfen, G. Nizzoli, E. Sugliano, M. Crosti, M. Moro, B. Steckel, S. Steinfelder, K. Stölzel, C. Romagnani, F. Botti, F. Caprioli, M. Pagani, S. Abrignani, J. Geginat
Serum microRNAs as biomarkers of human lymphocyte activation in health and disease
2014 P. de Candia, A. Torri, M. Pagani, S. Abrignani
Third trimester NG2-positive amniotic fluid cells are effective in improving repair in spinal cord injury
2014 D. Bottai, G. Scesa, D. Cigognini, R. Adami, E. Nicora, S. Abrignani, A.M. Di Giulio, A. Gorio
Why is it so difficult to develop a hepatitis C virus preventive vaccine?
2014 C. Zingaretti, R. De Francesco, S. Abrignani
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile